Torrey Growth & Income Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Torrey Growth & Income Advisors's LLY Position: Q2 2026 in Review
Torrey Growth & Income Advisors increased its Eli Lilly (LLY) stake by 0.02% in Q2 2026, buying an estimated $1.02K and bringing the position to 5,248 shares worth $6.34M. The position accounts for 2.15% of the portfolio, ranked #10.
Torrey Growth & Income Advisors first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Torrey Growth & Income Advisors held 5,248 shares of Eli Lilly worth $6.34M as of Q2 2026.
- Torrey Growth & Income Advisors bought 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
- Eli Lilly made up 2.15% of Torrey Growth & Income Advisors's portfolio in Q2 2026, its #10 holding.
- Torrey Growth & Income Advisors first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
- 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Torrey Growth & Income Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.